Alternatives to mifepristone for early medical abortion
| Autor: | Nathalie Kapp, Ellen Wiebe, Beverly Winikoff, Nilda Moreno-Ruiz, Lynn Borgatta, S. Yanow |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Abortion Incomplete Abortion Pharmacotherapy Pregnancy medicine Humans Misoprostol business.industry Obstetrics Abortifacient Agents Steroidal Obstetrics and Gynecology Abortion Induced General Medicine Mifepristone medicine.disease Medical abortion Pregnancy Trimester First Methotrexate Drug Therapy Combination Female business medicine.drug |
| Zdroj: | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 96(3) |
| ISSN: | 0020-7292 |
| Popis: | Objective To review published reports of first-trimester medical abortion regimens that do not include mifepristone. Methods Reports listed in Pubmed and Medline on prospective and controlled trials of the efficacy of misoprostol, alone or associated with methotrexate, for first-trimester abortion were analyzed if they included more than 100 participants and were published since 1990. Results The efficacy of regimens using misoprostol alone ranged from 84% to 96%, and when misoprostol was used with methotrexate the efficacy ranged from 70% to 97%. Efficacy rates were influenced by follow-up interval. Treatment for infection, bleeding, and incomplete abortion were infrequent with both methods (0.3%–5%). Conclusion Alone or in combination with methotrexate, misoprostol is an efficacious alternative to mifepristone for the medical termination of pregnancy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text